ロード中...
Type 2 diabetes, thiazolidinediones, and cardiovascular risk
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Royal College of General Practitioners
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2702020/ https://ncbi.nlm.nih.gov/pubmed/19567003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3399/bjgp09X453440 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|